Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-14-073172

Chief Financial Officer bought 2,000 shares at an average $3.20 ($6,400)

From the SEC's structured data for this filing

Trades in this filing

Moran Sean F. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2014-12-04 Purchase : show line 1 in the form +1,000 $3.15 $3,150 6,000 D
2014-12-04 Purchase : show line 2 in the form +1,000 $3.25 $3,250 7,000 D
Open-market purchases · 2,000 sh · avg $3.20 · $6,400
Loading xslF345X03/doc4.xml…